Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer
Open Access
- 30 August 2011
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 71 (17) , 5891-5903
Abstract
We use hepatic cellular carcinoma (HCC), one of the most common human cancers, as a model to delineate the landscape of promoter hypomethylation in cancer. Using a combination of methylated DNA immunoprecipitation and hybridization with comprehensive promoter arrays, we have identified approximately 3,700 promoters that are hypomethylated in tumor samples. The hypomethylated promoters appeared in clusters across the genome suggesting that a high-level organization underlies the epigenomic changes in cancer. In normal liver, most hypomethylated promoters showed an intermediate level of methylation and expression, however, high-CpG dense promoters showed the most profound increase in gene expression. The demethylated genes are mainly involved in cell growth, cell adhesion and communication, signal transduction, mobility, and invasion; functions that are essential for cancer progression and metastasis. The DNA methylation inhibitor, 5-aza-2′-deoxycytidine, activated several of the genes that are demethylated and induced in tumors, supporting a causal role for demethylation in activation of these genes. Previous studies suggested that MBD2 was involved in demethylation of specific human breast and prostate cancer genes. Whereas MBD2 depletion in normal liver cells had little or no effect, we found that its depletion in human HCC and adenocarcinoma cells resulted in suppression of cell growth, anchorage-independent growth and invasiveness as well as an increase in promoter methylation and silencing of several of the genes that are hypomethylated in tumors. Taken together, the findings define the potential functional role of hypomethylation in cancer. Cancer Res; 71(17); 5891–903. ©2011 AACR.Keywords
All Related Versions
This publication has 42 references indexed in Scilit:
- Methylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylationNucleic Acids Research, 2009
- Agglomerative Epigenetic Aberrations Are a Common Event in Human Breast CancerCancer Research, 2008
- MeCP2, a Key Contributor to Neurological Disease, Activates and Represses TranscriptionScience, 2008
- High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancerProceedings of the National Academy of Sciences, 2008
- DNA methylation analysis by pyrosequencingNature Protocols, 2007
- Epigenetic Programming of the rRNA Promoter by MBD3Molecular and Cellular Biology, 2007
- A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promotersProceedings of the National Academy of Sciences, 2006
- DNA Methylation Profiling of the Human Major Histocompatibility Complex: A Pilot Study for the Human Epigenome ProjectPLOS Biology, 2004
- Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profilingOncogene, 2003
- DNA methylation in cancer: too much, but also too littleOncogene, 2002